These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 28963773)

  • 1. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
    Toor SM; Syed Khaja AS; Alkurd I; Elkord E
    Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcus aureus convert neonatal conventional CD4(+) T cells into FOXP3(+) CD25(+) CD127(low) T cells via the PD-1/PD-L1 axis.
    Rabe H; Nordström I; Andersson K; Lundell AC; Rudin A
    Immunology; 2014 Mar; 141(3):467-81. PubMed ID: 24708420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
    Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
    Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low expressions of PD-L1 and CTLA-4 by induced CD4
    Zhao L; Zhou X; Zhou X; Wang H; Gu L; Ke Y; Zhang M; Ji X; Yang X
    Cytokine; 2020 Sep; 133():155119. PubMed ID: 32535334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pembrolizumab Interferes with the Differentiation of Human FOXP3
    Sasidharan Nair V; Toor SM; Taouk G; Pfister G; Ouararhni K; Alajez NM; Elkord E
    J Immunol; 2020 Jan; 204(1):199-211. PubMed ID: 31801817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
    Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
    Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biophysical and Immunological Characterization and
    Hutchins B; Starling GC; McCoy MA; Herzyk D; Poulet FM; Dulos J; Liu L; Kang SP; Fayadat-Dilman L; Hsieh M; Andrews CL; Ayanoglu G; Cullen C; Malefyt RW; Kastelein RA; Saux SL; Lee J; Li S; Malashock D; Sadekova S; Soder G; van Eenennaam H; Willingham A; Yu Y; Streuli M; Carven GJ; van Elsas A
    Mol Cancer Ther; 2020 Jun; 19(6):1298-1307. PubMed ID: 32229606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High programmed death 1 expression on T cells in aplastic anemia.
    Zhao W; Zhang Y; Zhang P; Yang J; Zhang L; He A; Zhang W; Hideto T
    Immunol Lett; 2017 Mar; 183():44-51. PubMed ID: 28153603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foxp3
    Liu L; Zhang Q; Chen P; Guo N; Song A; Huang X; Xia W; Li L; Moog C; Wu H; Su B; Zhang T
    BMC Immunol; 2019 Oct; 20(1):38. PubMed ID: 31651258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD8
    Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
    Front Immunol; 2018; 9():2788. PubMed ID: 30555473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity.
    Ferreira RC; Simons HZ; Thompson WS; Rainbow DB; Yang X; Cutler AJ; Oliveira J; Castro Dopico X; Smyth DJ; Savinykh N; Mashar M; Vyse TJ; Dunger DB; Baxendale H; Chandra A; Wallace C; Todd JA; Wicker LS; Pekalski ML
    J Autoimmun; 2017 Nov; 84():75-86. PubMed ID: 28747257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pembrolizumab on CD4
    Toor SM; Sasidharan Nair V; Pfister G; Elkord E
    Clin Exp Immunol; 2019 Jun; 196(3):345-352. PubMed ID: 30693485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequencies of regulatory subsets of CD4
    Saikia L; Deka T; Deori P; Roy R; Hussain ME; Nath R
    Indian J Med Microbiol; 2019; 37(3):370-375. PubMed ID: 32003335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional heterogeneity of circulating T regulatory cell subsets in breast cancer patients.
    Ostapchuk YO; Perfilyeva YV; Kustova EA; Urazalieva NT; Omarbaeva NA; Talaeva SG; Belyaev NN
    Breast Cancer; 2018 Nov; 25(6):687-697. PubMed ID: 29797233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The characteristic profiles of PD-1 and PD-L1 expressions and dynamic changes during treatment in active tuberculosis.
    Shen L; Shi H; Gao Y; Ou Q; Liu Q; Liu Y; Wu J; Zhang W; Fan L; Shao L
    Tuberculosis (Edinb); 2016 Dec; 101():146-150. PubMed ID: 27865385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human umbilical vein endothelial cells promote the inhibitory activation of CD4(+)CD25(+)Foxp3(+) regulatory T cells via PD-L1.
    Chen WJ; Hu XF; Yan M; Zhang WY; Mao XB; Shu YW
    Atherosclerosis; 2016 Jan; 244():108-12. PubMed ID: 26615520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T-cell-mediated immune response via the PD-1/ PD-L1 axis in cholangiocarcinoma cells.
    Suriyo T; Fuangthong M; Artpradit C; Ungtrakul T; Sricharunrat T; Taha F; Satayavivad J
    Eur J Pharmacol; 2021 Apr; 897():173960. PubMed ID: 33617828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of PD-1 blockade in cervical cancer is related to a CD8
    Heeren AM; Rotman J; Stam AGM; Pocorni N; Gassama AA; Samuels S; Bleeker MCG; Mom CH; Zijlmans HJMAA; Kenter GG; Jordanova ES; de Gruijl TD
    J Immunother Cancer; 2019 Feb; 7(1):43. PubMed ID: 30755279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining FoxP3 and Helios with GARP/LAP markers can identify expanded Treg subsets in cancer patients.
    Abd Al Samid M; Chaudhary B; Khaled YS; Ammori BJ; Elkord E
    Oncotarget; 2016 Mar; 7(12):14083-94. PubMed ID: 26885615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.